136 related articles for article (PubMed ID: 15254560)
41. The value of cord blood interleukin-6 levels for predicting chorioamnionitis, funisitis and neonatal infection in term premature rupture of membranes.
Tasci Y; Dilbaz B; Uzmez Onal B; Caliskan E; Dilbaz S; Doganci L; Han U
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):34-9. PubMed ID: 16459014
[TBL] [Abstract][Full Text] [Related]
42. [Current problems of ante- and perinatal pathology].
Milovanov AP; Ivanovskaia TE; Kask LN; Mironova OS
Vestn Akad Med Nauk SSSR; 1991; (5):3-7. PubMed ID: 1866998
[TBL] [Abstract][Full Text] [Related]
43. Stillbirth and fetal growth restriction.
Serena C; Marchetti G; Rambaldi MP; Ottanelli S; Di Tommaso M; Avagliano L; Pieralli A; Mello G; Mecacci F
J Matern Fetal Neonatal Med; 2013 Jan; 26(1):16-20. PubMed ID: 22882114
[TBL] [Abstract][Full Text] [Related]
44. Factors influencing the percentage of second trimester abortions in the Netherlands.
Loeber O; Wijsen C
Reprod Health Matters; 2008 May; 16(31 Suppl):30-6. PubMed ID: 18772081
[TBL] [Abstract][Full Text] [Related]
45. Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction.
Rodie VA; Young A; Jordan F; Sattar N; Greer IA; Freeman DJ
J Soc Gynecol Investig; 2005 Jul; 12(5):320-9. PubMed ID: 15979543
[TBL] [Abstract][Full Text] [Related]
46. Cervicovaginal infections during pregnancy: epidemiological and microbiological aspects.
Benedetto C; Tibaldi C; Marozio L; Marini S; Masuelli G; Pelissetto S; Sozzani P; Latino MA
J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():9-12. PubMed ID: 15590426
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
[TBL] [Abstract][Full Text] [Related]
48. First-trimester intrauterine hematoma and outcome of pregnancy.
Maso G; D'Ottavio G; De Seta F; Sartore A; Piccoli M; Mandruzzato G
Obstet Gynecol; 2005 Feb; 105(2):339-44. PubMed ID: 15684162
[TBL] [Abstract][Full Text] [Related]
49. [Fetopathological examination and congenital anomalies in the third trimester].
Carles D; Pelluard F; Alberti EM; Gangbo F
Bull Acad Natl Med; 2005 Nov; 189(8):1789-99; discussion 1799-801. PubMed ID: 16737103
[TBL] [Abstract][Full Text] [Related]
50. Toll-like receptor-2 expression in normal and pathologic human placenta.
Rindsjö E; Holmlund U; Sverremark-Ekström E; Papadogiannakis N; Scheynius A
Hum Pathol; 2007 Mar; 38(3):468-73. PubMed ID: 17239937
[TBL] [Abstract][Full Text] [Related]
51. Intrauterine device usage and fetal loss.
Foreman H; Stadel BV; Schlesselman S
Obstet Gynecol; 1981 Dec; 58(6):669-77. PubMed ID: 7312231
[No Abstract] [Full Text] [Related]
52. [A retrospective study on the association of sexual behavior during pregnancy with intrauterine infection of hepatitis B virus].
Shao ZJ; Xu DZ; Xu JQ; Men K; Yan YP; Zhang L; Zhang JX
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):232-5. PubMed ID: 15941524
[TBL] [Abstract][Full Text] [Related]
53. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil.
Suzano CE; Amaral E; Sato HK; Papaiordanou PM;
Vaccine; 2006 Feb; 24(9):1421-6. PubMed ID: 16236402
[TBL] [Abstract][Full Text] [Related]
54. Adverse reproductive outcomes in urban women with adeno-associated virus-2 infections in early pregnancy.
Arechavaleta-Velasco F; Gomez L; Ma Y; Zhao J; McGrath CM; Sammel MD; Nelson DB; Parry S
Hum Reprod; 2008 Jan; 23(1):29-36. PubMed ID: 17977863
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological evaluation of 59 cases of fetal death.
Zanconato G; Piazzola E; Caloi E; Iacovella C; Ruffo R; Franchi M
Arch Gynecol Obstet; 2007 Dec; 276(6):619-23. PubMed ID: 17541617
[TBL] [Abstract][Full Text] [Related]
56. Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986-1995.
Frøen JF; Arnestad M; Frey K; Vege A; Saugstad OD; Stray-Pedersen B
Am J Obstet Gynecol; 2001 Mar; 184(4):694-702. PubMed ID: 11262474
[TBL] [Abstract][Full Text] [Related]
57. Individual risk of fetal loss following routine second trimester amniocentesis: a controlled study of 20,460 cases.
Kozlowski P; Knippel A; Stressig R
Ultraschall Med; 2008 Apr; 29(2):165-72. PubMed ID: 17602371
[TBL] [Abstract][Full Text] [Related]
58. The Alabama preterm birth study: corticosteroids and neonatal outcomes in 23- to 32-week newborns with various markers of intrauterine infection.
Goldenberg RL; Andrews WW; Faye-Petersen OM; Cliver SP; Goepfert AR; Hauth JC
Am J Obstet Gynecol; 2006 Oct; 195(4):1020-4. PubMed ID: 17000235
[TBL] [Abstract][Full Text] [Related]
59. Unexplained intrauterine fetal death is accompanied by activation of complement.
Richani K; Romero R; Soto E; Espinoza J; Nien JK; Chaiworapongsa T; Refuerzo J; Blackwell S; Edwin SS; Santolaya-Forgas J; Mazor M
J Perinat Med; 2005; 33(4):296-305. PubMed ID: 16207114
[TBL] [Abstract][Full Text] [Related]
60. Pregnancy outcome following recurrent spontaneous abortions.
Sheiner E; Levy A; Katz M; Mazor M
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):61-5. PubMed ID: 15596274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
